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Abstract
Dystonia is a neurological movement disorder that forces the body into twisting, repetitive movements or sometimes painful
abnormal postures. With the advent of next-generation sequencing technologies, the homozygous mutations T71N and
A190T in the neuronal calcium sensor (NCS) hippocalcin were identified as the genetic cause of primary isolated dystonia
(DYT2 dystonia). However, the effect of these mutations on the physiological role of hippocalcin has not yet been elucidated.
Using a multidisciplinary approach, we demonstrated that hippocalcin oligomerises in a calcium-dependent manner and
binds to voltage-gated calcium channels. Mutations T71N and A190T in hippocalcin did not affect stability, calcium-binding
affinity or translocation to cellular membranes (Ca2þ/myristoyl switch). We obtained the first crystal structure of hippocalcin
and alignment with other NCS proteins showed significant variability in the orientation of the C-terminal part of the mole-
cule, the region expected to be important for target binding. We demonstrated that the disease-causing mutations did not
affect the structure of the protein, however both mutants showed a defect in oligomerisation. In addition, we observed an
increased calcium influx in KCl-depolarised cells expressing mutated hippocalcin, mostly driven by N-type voltage-gated
calcium channels. Our data demonstrate that the dystonia-causing mutations strongly affect hippocalcin cellular functions
which suggest a central role for perturbed calcium signalling in DYT2 dystonia.
Introduction
Dystonia is a movement disorder that causes muscle spasms
and contractions. It is characterized by sustained or intermit-
tent muscle contractions causing abnormal, often repetitive
movements and painful postures than can be accompanied by
dystonic tremor (1). Dystonia may be classified according to its
distribution (2) or as primary or secondary (3). In contrast to
secondary dystonia that can be caused by brain damage
(head injury, stroke) or exposure to particular drugs, the
pathophysiological mechanisms of most forms of primary
dystonia are unknown (4). Recently, using a combination of
homozygosity mapping and whole-exome next-generation
sequencing in a consanguineous kindred affected by
autosomal-recessive isolated dystonia, homozygous mutations
were observed in the genes LAPTM5, coding for a lysosomal
transmembrane protein and HPCA, encoding the calcium-
binding protein hippocalcin. After in silico analysis, hippocalcin
was identified as the most plausible cause for DYT2 primary iso-
lated dystonia (5). HPCA or hippocalcin, is a member of the
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neuronal calcium sensor (NCS) protein family (6) and is highly
expressed in hippocampal pyramidal CA1 neurons, in particular
in their dendrites (7–9). It contains four EF-hands out of which
only three are capable of binding calcium. In response to
increased intracellular calcium, hippocalcin undergoes a con-
formational change and translocates from the cytosol to cellular
membranes through a Ca2þ/myristoyl switch mechanism (10).
The extrusion of the myristoyl-containing hydrophobic N-ter-
minus region from the hydrophobic pocket (11) allows hippocal-
cin to localize to membranes where it can interact with
downstream targets (10,12,13). In addition to its role in the con-
trol of apoptosis (14), hippocalcin has been shown to be
involved in neuronal excitability (15–17), regulation of neurite
outgrowth (18) and gene transcription (19,20), long-term depres-
sion (21–23) and the modulation of cyclic nucleotide signalling
(24). Mutations at positions T71N and A190T were shown to be
critical in development of DYT2 dystonia (5). It was speculated
that T71N mutation could impair or prevent calcium binding to
EF-hand domain 2, possibly leading to a loss of function,
whereas A190T could be involved in target specificity. However,
no direct evidence was provided to support these hypotheses.
In this study, we investigate the effect of the dystonia-
causing mutations on the biophysical and physiological
properties of hippocalcin. We demonstrate that hippocalcin oli-
gomerises upon calcium binding and interacts with voltage-
gated calcium channels (VGCCs). We observed that the struc-
ture, stability and calcium-binding properties of the mutants
remain unchanged. Both mutants, however, show strong oligo-
merisation defects and increased intracellular calcium influx.
These results suggest that the cause of the disease is not due to
loss of hippocalcin expression or stability but to subtle changes
in its ability to participate in calcium signalling.
Results
Calcium binding and stability properties of hippocalcin-
mutant proteins remain unchanged
To determine if the calcium-binding properties of hippocalcin
were altered by the mutations, equilibrium calcium-binding
titrations were performed using intrinsic tryptophan fluores-
cence (Fig. 1). Free calcium concentrations ([Ca2þ]) were calcu-
lated using the Maxchelator program (25) and were verified
using OGB-1 (Supplementary Material, Fig. S1). In order to deter-
mine the dissociation constant (Kd) and the Hill coefficient (n),
calcium titrations were normalised and fitted to the Hill equa-
tion (correlation coefficient values between 0.96 and 0.98).
Hippocalcin wild-type had a Kd of 656 4 nM and a Hill coefficient
(n) of 1.460.1. As expected, hippocalcin(A190T) presented simi-
lar calcium-binding properties to the wild-type protein with
Kd¼ 7765 nM and n¼ 1.360.1 (Table 1). Affinities for calcium
for hippocalcin(T71N) (Kd¼ 93612 nM) was not significantly dif-
ferent from the wild-type, even though the mutation was
located within the second EF-hand of hippocalcin. However, the
cooperativity of calcium binding, shown by the Hill coefficient,
significantly decreased from n¼ 1.46 0.1 for the wild-type, to
n¼ 0.760.1 for hippocalcin(T71N).
Stability of hippocalcin proteins was determined by trypsin
limited proteolysis and temperature/chemical denaturation
(Supplementary Material, Fig. S2). Incubation of wild-type hip-
pocalcin with trypsin showed 326 14% degradation over 30 min
(Supplementary Material, Fig. S2A). Similar susceptibility to pro-
tease degradation was observed for both mutants. In addition,
a-helices temperature unfolding followed by circular dichroism
revealed that hippocalcin is a very thermostable protein with
only 37% of a-helices denaturation at 90 C, and that the muta-
tions did not alter the temperature stability of the protein
(Supplementary Material, Fig. S2B). Guanidine denaturation
monitored by intrinsic tryptophan fluorescence showed com-
plete protein denaturation at [Gnd-HCl] of 3 M (Supplementary
Material, Fig. S2C). When comparing the susceptibility to guani-
dine of hippocalcin wild-type with the mutants, no significant
difference was observed. Altogether, these data suggest that the
disease-causing mutations T71N and A190T are not affecting
the stability of the proteins.
Disease-causing mutants have a similar secondary and
3D structure to the parent protein
Circular dichroism (CD) spectroscopy was used to examine
whether the mutations in hippocalcin were causing secondary
structure modifications. CD spectra were collected for hippocalcin
and the mutants in either apo- or calcium-bound form
(Supplementary Material, Fig. S3A). After protein secondary struc-
ture prediction using the CDSSTR method, the helical content of
hippocalcin was estimated to 75% of a-helices and only 9% of b-
sheets (Supplementary Material, Fig. S3B). The conformational
change that occurs upon calcium binding did not affect the sec-
ondary structure content, neither did the mutations.
Crystal structures were obtained for wild-type human
hippocalcin (PDB 5G4P), hippocalcin(T71N) (PDB 5M6C) and
hippocalcin(A190T) (PDB 5G58) at a resolution of the 2.42, 3.00
and 2.54 A˚, respectively. Data collection and refinement statis-
tics are presented in Supplementary Material, Table S1. The
structure of hippocalcin is similar to all NCS proteins and con-
tains 4 EF-hands (helix-loop-helix motifs) and 10 a-helices
(Supplementary Material, Fig. S4A). Electron density revealed
three calcium ions in EF-2, EF-3 and EF-4 binding sites (Fig. 2A)
Figure 1. Equilibrium Ca2þ-binding titrations for hippocalcin wild-type and
mutants measured by intrinsic tryptophan fluorescence at 20 C. Fluorescence
changes (kex¼280 nm and kem¼340 nm) are normalised to F0 of 0 and Fmax of 1
and fitted to the Hill equation. Fitted curves are represented by solid lines over-
laying the data points. Titrations were performed at least in triplicates and rep-
resented as mean6SEM.
Table 1. Calcium-binding properties of HPCA wild-type and disease-
causing mutants
Kd (nM) n R
2
OGB-1 1326 11 1 0.97
HPCA 656 4 1.4 6 0.1 0.98
HPCA T71N 936 12 0.7 6 0.1* 0.96
HPCA A190T 776 5 1.3 6 0.1 0.97
*P<0.01, compared to HPCA wild-type, student t-test.
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in all structures. Cryptic EF-hand 1 did not bind any calcium
ions, as expected. The regions involved in calcium binding
showed complete preservation and high order. As many NCS
proteins, hippocalcin has two lobes, N-lobe is formed by EF-1
and EF-2, while C-lobe is formed by EF-3 and EF-4. The crystal
structure contained two copies of hippocalcin in the asymmet-
ric unit connected by insertion of C-terminal helix of chain E
(residues 181–190) into the hydrophobic groove of chain A. This
packing is facilitated by salt bridge between guanidinium group
of Arg181 and carboxyl group of Asp37, and hydrogen bond
between OE1 Gln184 and NE1 Trp30 (Supplementary Material,
Fig. S4B). Interestingly, the same fragment is expected to be
involved in target binding. PISA analysis of the oligomeric states
for all three proteins has confirmed that they are monomeric in
solution. Alignment of Ca atoms of hippocalcin with other
calcium-binding proteins such as rat NCS-1 (PDB 5AEQ) and
bovine neurocalcin delta (PDB 1BJF) showed significant variabil-
ity in the orientation of the C-terminal part of the molecule,
region expected to be involved in specificity of target binding
(Fig. 2B). In addition, significant variability was observed in the
loop regions, with exception of the EF-hand loops (Fig. 2C).
Comparison of hippocalcin with the dimeric crystal structure of
bovine neurocalcin delta (PDB 1BJF), suggest a key role of the
calcium EF-hands for oligomerisation as they seem to be located
at the dimerization interface and are structurally identical in 3
proteins (Fig. 2C). The crystal structure of hippocalcin(T71N)
and hippocalcin(A190T) did not show any significant conforma-
tion difference when compared to the wild-type protein and
they have identical crystal packing (Supplementary Material,
Fig. S4C). Mutation site in hippocalcin T71N is located on the
interface between N-lobe and C-lobe close to the area of interac-
tion with peptides in NCS-1 (26), change from Thr to Asn
strengthens inter-lobe interface by creating additional hydrogen
bond between ND2 Asn71 and OG Ser106 (Supplementary
Material, Fig. S4D). Mutation A190T is located at the end of the
flexible C-terminal helix (Supplementary Material, Fig. S4E),
which is predicted to interact with hippocalcin target protein.
Change from Ala to Thr does not decrease C-terminus
flexibility.This part has no electron density in chain A.
Hippocalcin forms multimers in the presence of calcium
and disease-causing mutants show a strong oligomer-
isation defect
Absolute molar masses of hippocalcin wild-type and mutants
were accurately determined by SEC-MALS, overcoming the
limitation of column calibration. MALS data indicated that in
the absence of calcium, hippocalcin was 99% monomeric
(23.16 0.2 kDa) (Fig. 3, Supplementary Material, Table S2).
However, in the presence of 1 mM calcium, hippocalcin formed
a mixture of monomers (25.16 0.9 kDa) and oligomers with a
molar mass consistent with dimer (46.761.1 kDa), trimer
(68.26 1.9 kDa) and tetramer (91.662.9 kDa) molecules. The oli-
gomeric fraction represented more than 57% of the total
proteins. As with the parent protein hippocalcin, the
hippocalcin(T71N) and hippocalcin(A190T) proteins were mono-
disperse in the absence of calcium with a size consistent with a
monomer (23.26 0.2 kDa on average) and formed oligomers in a
calcium-dependent manner (Fig. 3B). The calcium-dependent
oligomerisation was also observed in in vitro crosslink (BS3 or
DSP) experiments (Supplementary Material, Fig. S5A–C). Indeed,
densitometry quantification after DSP crosslinking on hippocal-
cin purified protein showed that calcium significantly increased
the polydispersity of the sample (from 2463% oligomers in the
absence of calcium, to 526 1% oligomers in the presence of cal-
cium). Treatment with DTT after DSP crosslinking cleaved the
oligomers back into monomers, as expected (Supplementary
Material, Fig. S5B). Oligomerisation also occurred at low calcium
concentrations (50 lM) (Supplementary Material, Fig. S5C).
Intracellular crosslink in N2A cells using DSP reproduced the
calcium-dependent oligomerisation of hippocalcin, in a physio-
logical context (Supplementary Material, Fig. S5D).
Oligomerisation upon calcium binding was also observed
for the disease-causing mutants hippocalcin(T71N) and
hippocalcin(A190T) (Fig. 3B, Supplementary Material, Fig.
S5A,B,D). However, the mutations significantly decreased the
oligomer formation when compared to the wild-type protein
(Supplementary Material, Fig. S5B). Indeed, the fraction of
oligomers measured by MALS was reduced from 57% for the
wild-type protein to 19–28% for the mutants (Fig. 3B). Using a
combination of biochemical and biophysical techniques, we
demonstrated the calcium-dependent oligomerisation of hippo-
calcin and a strong defect in oligomer formation for the
dystonia-causing mutants.
Hippocalcin and mutants bind to P/Q- and N-type
voltage-gated calcium channels (VGCCs)
Hippocalcin wild-type has been shown to affect cellular response
to membrane depolarisation and it has been suggested that hip-
pocalcin might play a role in regulating voltage-dependent cal-
cium channels (5). However, there is yet no direct evidence of
Figure 2. Cartoon representation of the crystal structure of the wild-type hippocalcin and its comparison with the structures of other calcium-binding proteins.
(A) Wild-type human hippocalcin (magenta) with 3 Ca2þ ions (orange spheres) bound at EF-2, EF-3 and EF-4 sites. Alignment of human hippocalcin crystal structure
(magenta) with (B) rat NCS-1 (blue) (PDB 5AEQ) and bovine neurocalcin delta (green) (PDB 1BJF), revealing a different orientation of the C-terminal region of the mole-
cule; (C) rat NCS-1 (blue) (PDB 5AEQ) and dimeric bovine neurocalcin delta (green) (PDB 1BJF), showing structural conservation of the EF-hands, located at the dimeriza-
tion interface.
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hippocalcin interacting with VGCCs. In this study, we investigate
the interaction of hippocalcin with P/Q- and N-type channels as
other NCS family members have been shown to bind to these
channel subtypes (27–29), thought to be drivers of synaptic trans-
mission (30). We demonstrate, using purified proteins and west-
ern blots, that hippocalcin wild-type and mutants bound to both
P/Q- (residues 1898-2035) and N-type (residues 1836-1983) VGCC
fragment proteins whereas no significant binding to the SUMO
protein control was detected (Fig. 4A). In addition, after densitom-
etry quantification using biotinylated BSA as loading control, we
observed that both mutants also bound to the channel fragments
and that hippocalcin(A190T) interaction with VGCCs was altered
(Fig. 4B). Indeed in the absence of calcium, hippocalcin(A190T)
presented increased interaction with N-type channels when
compared to the wild-type. In the presence of low lM calcium
hippocalcin(A190T) showed significantly enhanced binding to
both P/Q- and N-type calcium channels, compared to the parent
protein. We have been unable to confirm this interaction for
native channel subunits using immunoprecipation techniques as
an effective anti-hippocalcin antiserum is currently not available.
Functional characterisation of hippocalcin wild-type
and mutants
Differentiated SH-SY5Y cells were transfected with mCherry-
tagged hippocalcin constructs and loaded with Fluo-4 calcium
dye. Expression levels were verified by Western blot using actin,
calnexin and tubulin as loading controls and did not show
any difference between the wild-type and the mutants
(Supplementary Material, Fig. S6). After 50 mM KCl stimulation
to depolarise the cells, calcium signals were monitored on a
spinning-disk confocal microscope (Fig. 5). Cells transfected
with hippocalcin wild-type showed 27% increase in intracellular
fluorescence after KCl depolarisation. For the dystonia-causing
mutants hippocalcin(T71N) and hippocalcin(A190T), calcium
influx upon stimulation significantly increased to 51% and 62%,
respectively, compared to hippocalcin wild-type (Fig. 5B). We
set out to determine which type of calcium channel mediated
the increased calcium influx by testing the effect of
calcium channel blockers on cells expressing wild type hippo-
calcin or hippocalcin(A190T). For both hippocalcin- and
hippocalcin(A190T)-transfected cells, incubation with x-aga-
toxin IVA (P/Q-type channel blocker) did not significantly affect
calcium influx upon KCl-induced depolarisation (Fig. 5C).
However, we observed a large decrease of the calcium response
in the presence of x-conotoxin MVIIC (P/Q- and N-type channel
blocker) and x-conotoxin GVIA (N-type channel blocker). For
both hippocalcin and hippocalcin(A190T), fluorescence calcium
signal decreased by 60% in the presence of x-conotoxin MVIIC
and 50% in the presence of x-conotoxin GVIA. These results
suggest that the increased calcium response due to
hippocalcin(A190T) expression was predominantly due to cal-
cium entry through N-type calcium channels.
After rapid calcium photorelease, hippocalcin translocation
to the preinuclear region of the cells was observed
(Supplementary Material, Fig. S7A). This was, as previously
demonstrated by O’Callaghan and coworkers, to be due to trans-
location to the trans-Golgi network (TGN) (10,31). Time-courses
of Fluo-4 (calcium indicator) and hippocalcin fluorescence
revealed that translocation is calcium-dependent and that it
occurred rapidly after calcium rise (Supplementary Material,
Fig. S7B). Photocleavage of NP-EGTA to rapidly release intracel-
lular calcium also induced translocation of hippocalcin(T71N)
and hippocalcin(A190T) mutants to the TGN.
Discussion
Dysregulation in calcium homeostasis and signalling have been
implicated in many aspects of neuropathology, neurodegenera-
tion and psychiatric disorders (32–36). In this paper, we investi-
gated the role of mutations in hippocalcin, a neuronal calcium
sensor involved in DYT2 dystonia disease. Using a combination
of biophysical, structural biology and cell biology techniques, we
demonstrated that the disease-causing mutations T71N and
A190T have an effect on key functional properties of hippocalcin.
In many cases disease-causing mutations can affect protein
folding and/or reduce protein stability leading to a loss of
expression levels. This was not the case for the DYT2 hippocal-
cin mutations. Biophysical experiments showed that all hippo-
calcin mutants had similar CD spectrum with no altered protein
stability when compared to the wild-type protein. Heat-
denaturation studies revealed that hippocalcin is a very ther-
mostable protein, as observed for other calcium-binding protein
such as VILIP-1 with unfolding temperature Tm> 110 C (37),
Calmodulin and Troponin C (Tm> 90 C) (38). The Ca
2þ-binding
data were performed using unmyristoylated hippocalcin. There
is no evidence available on whether myristoylation affects the
Ca2þ binding to hippocalcin. While we cannot exclude minor
effects, analysis of the unmyristoylated hippocalcin proteins
should allow us to detect any differences in the intrinsic Ca2þ
Figure 3. Defect of oligomerisation for hippocalcin mutants measured by SEC-
MALS. (A) Representative SEC-MALS data obtained for hippocalcin wild-type
showing a monodisperse sample in the presence of 5 mM EGTA (red) (consistent
with a monomer) compared to a polydisperse sample in the presence of 1 mM
CaCl2 (black) (consistent with a mixture of monomer, dimer, trimer and tet-
ramer). The average molar mass is indicated in dotted line and the differential
refractive index in plain line. (B) Analysis of the MALS data for hippocalcin wild-
type and mutants in the presence or absence of Ca2þ. Molar mass of each peak
is shown in Supplementary Material, Table S2.
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affinity of the wild-type compared to the mutants. Equilibrium
calcium-binding titrations showed that hippocalcin has a high
affinity for calcium binding (Kd¼ 65 nM) with positive coopera-
tivity (n¼ 1.4) as observed for other NCS proteins such as VILIP-1
(37), recoverin (39,40) and neurocalcin delta (39,41). Surprisingly,
mutation hippocalcin(T71N), located within the second EF-
hand, did not alter the overall calcium- binding affinity but sig-
nificantly reduced the calcium-binding cooperativity. Previous
studies on VILIP-1 and recoverin revealed that two calcium ions
bind sequentially, first at EF-3 (high affinity) to facilitate cooper-
ative calcium binding at EF-2 (low affinity) (37,40). Because EF-2
has low affinity for calcium (lM), mutations in this domain in
hippocalcin may not have any significant effect on the overall
dissociation constant. The equilibrium calcium-binding titra-
tions for hippocalcin and hippocalcin(A190T) show that a cal-
cium concentration of 1 lM is sufficient to get the protein fully
Ca2þ-bound. However, the decrease in cooperativity observed
for hippocalcin(T71N) suggests that at low lM [Ca2þ],
hippocalcin(T71N) will only be partially Ca2þ-bound which then
could affect regulation of downstream calcium signalling cas-
cades in stimulated cells.
Hippocalcin shares common structural features of NCS pro-
teins of 200 residue chain containing 4 EF-hand motifs and an
N-terminal myristoylation consensus sequence. The three
dimensional structures are known for NCS-1 (42,43), recoverin
(11,44) and neurocalcin delta (45). Here we provide the first crystal
structure for calcium-bound hippocalcin, hippocalcin(T71N) and
hippocalcin(A190T) with a resolution of 2.4–3.0 A˚. There is no sig-
nificant difference between the three structures. However, com-
parison of hippocalcin crystal structure with neurocalcin delta
and NCS-1 revealed a different orientation of the C-terminus part
of the protein. In NCS-1 the C-terminal tail appears to be able to
sit in the hydrophobic groove in the absence of ligand and there
is evidence to show that this tail acts as an auto-regulatory mech-
anism to control target binding (46–48); it is not clear at this stage
if the C-terminal tail of hippocalcin serves the same function but
it also sits in the hydrophobic groove in observed crystal packing
(Supplementary Material, Fig. S4C).
We demonstrated that hippocalcin oligomerises upon cal-
cium binding with molar masses consistent with dimers,
trimers and tetramers. We showed by in vitro crosslinking
experiments that 50 lM Ca2þ were sufficient to trigger oligomer
formation. In addition, we demonstrated that hippocalcin
oligomerises in cells stimulated with ionomycin, which raises
the intracellular calcium to 1 lM (49,50). Calcium concentra-
tion at a mouth of an open calcium channel is predicted to be
tens to hundreds of micromolar (51,52), suggesting that hippo-
calcin may bind to the channel as an oligomer. VILIP-1 and neu-
rocalcin delta, neuronal calcium sensors from the same family,
also forms an equilibrium mixture of monomeric and dimeric
protein species (37,53,54), in contrast to NCS-1 which is a mono-
meric protein (26). Disease-causing mutants of hippocalcin
showed a marked oligomerisation defect suggesting that EF-2
and the C-terminus domain are important for dimerization. In
addition, crystal structure of dimeric neurocalcin delta (PDB
1BJF) suggest an important role of the EF-hands in the oligomer-
isation of the protein, which we cannot confirm from our crystal
structures.
Upon intracellular calcium elevation, calcium sensor pro-
teins undergo a conformational change enabling interactions
with partners and regulation of various calcium signalling path-
ways (28). Hippocalcin exhibits a dynamic calcium association
in response to calcium increase and neuronal activity through a
Ca2þ/myristoyl switch mechanism (11). The change in confor-
mation induces its binding to cellular membranes where it can
interact with target proteins (10–12,55). Even though the bulk of
hippocalcin becomes translocated to the TGN, a proportion also
translocates to the plasma membrane (10,31), where it can
interact with VGGCs. The dystonia-causing mutation T71N and
A190T did not alter the translocation process.
Entry of extracellular calcium into synaptic terminals
through VGCCs is the driving force for exocytosis of
neurotransmitter-containing vesicles. Hippocalcin has been
implicated as a calcium sensor in long-term depression and the
gating of channels underlying a slow after-hyperpolarisation
current (16,21,56). However, no direct interaction with VGCCs
channels has been shown. In this paper, we demonstrated that
hippocalcin directly binds to the a-subunit of VGCCs of P/Q- and
N-type, which suggest a role of hippocalcin in neurotransmitter
release and synaptic plasticity. Hippocalcin(A190T) showed
increased binding to both channels compared to the wild-type
protein, suggesting that the mutation in the C-terminus region
is important for target interaction, as previously shown for
other NCS proteins (46,57). We demonstrated that hippocalcin
can bind to the VGCCs in the absence of calcium, suggesting a
pre-association to the pore-forming a-subunit of VGCCs as
Figure 4. Hippocalcin wild-type and mutants interact with P/Q- and N-type voltage-gated calcium channels. P/Q- (residues 1898-2035), N-type (residues 1836-1983)
VGCC fragments and SUMO protein were separated by SDS-PAGE and transferred to nitrocellulose. Binding proteins were detected with biotinylated hippocalcin or hip-
pocalcin mutants in the absence or presence of Ca2þ. (A) Representative overlay blot after detection with streptavidin-HRP. Lane 1: molecular weight ladder, lane 2:
SUMO-P/Q- purified protein, lane 3: SUMO-N-type purified protein, Lane 4: SUMO purified protein. Biotinylated BSA was added to the each sample and used as a loading
control. (B) Quantification of hippocalcin binding to the P/Q- and N-type VGCC fragments using ImageJ showed calcium-dependent altered binding of A190T mutant to
both P/Q- and N-type channels compared to the wild-type protein. All experiments were performed in 3-6 replicates and expressed as normalised mean6SEM.
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observed for apo-CaM (58–60). In cells transfected with hippo-
calcin mutants, we observed a significant increase in the cal-
cium response to KCl depolarisation, compared to wild-type
hippocalcin. Application of N-type calcium channel blockers
(x-conotoxins MVIIC and GVIA) dramatically reduced
calcium influx and the increased calcium signal due to
hippocalcin(A190T), whereas the P/Q channel blocker x-aga-
toxin IVA had no effect. These findings suggest that the effect of
hippocalcin mutants on calcium signalling is driven by interac-
tion and regulation of N-type calcium channels. Similarly, other
calcium-binding proteins such as CaM, CaBP1 and the NCS fam-
ily members NCS-1 and VILIP-2 have been reported to associate
with the a-subunit cytoplasmic regulatory domain of VGCCs of
P/Q-, N- and L-type to modulate channel opening and therefore
synaptic plasticity (27–29,61).
The binding to VGCCs of the mutants and the increased
intracellular calcium influx in stimulated cells could contribute
to a dysregulation of subsequent signalling pathways and result
in dramatic physiological alterations.
In summary, we demonstrated that hippocalcin forms
oligomers upon calcium binding and directly interacts with
VGCCs. The dystonia-causing mutations did not affect protein
stability or folding. In common for both T71N and A190T
mutants was an impaired calcium-dependent oligomerisation
and increased intracellular calcium influx after KCl depolarisa-
tion. These functional alterations suggest that the observed
defect in hippocalcin-dependent calcium signalling would have
important physiological consequences that contribute to the
onset of the disease.
Materials and Methods
Plasmids
A series of site-directed mutations were performed on pHippo-
EYFP expressing human hippocalcin following the QuikChange
protocol (Agilent Technologies) to generate pHPCA-EYFP con-
structs using the following primers: T71N, 5’-CGAGCATGTC
TTCCGCAATTTTGACACCAACAGCG-3’; A190T, 5’-GCGATCCCAGC
AGCACTTCCCAGTTCTCG-3’; and confirmed by DNA sequencing
(DNA sequencing and Services, University of Dundee). For
multi-color imaging, hippocalcin genes were subcloned from
pHPCA-EYFP into pEGFP-N1 or pmCherry-N1 vectors by
restriction-ligation (NheI/XmaI), generating pHPCA-EGFP and
pHPCA-mCherry constructs. For protein expression and purifica-
tion, hippocalcin genes were amplified by PCR from pHPCA-EYFP
vectors using the following primers: sense, 5’-CTATGAATTCATG
GGCAAGCAGAATAGC-3’; antisense: 5’-CTATCTCGAGTCAGAACTG
GGAAGCGCTGCTG-3’, and cloned by restriction-ligation into
pGEX-6P1 (EcoRI/XhoI). Residues 1898-2035 from rat P/Q-type cal-
cium channel asubunit (NM_012918) were amplified by PCR from
GST-PQ (62) using the following primers: sense, 5’-GGTCTCTAGG
TAAGTCCACGGCCTGACAG-3’; antisense, 5’-ATATCTCGAGCTAGG
GGAGGTAGTGTTCGCT-3’; and subcloned into pE-SUMO by
Figure 5. Dystonia-causing hippocalcin mutants increase depolarisation-induced calcium influx through N-type voltage-gated calcium channels. Differentiated SH-
SY5Y cells transfected with hippocalcin-mCherry constructs were loaded with Fluo-4 to monitor calcium concentration changes. After KCl depolarisation, live cells
were imaged on a spinning-disk confocal microscope. (A) Representative microscopy images of KCl-stimulated cells transfected with hippocalcin or
hippocalcin(A190T), showing intracellular calcium increase upon depolarisation. (B) Maximum intracellular calcium increase and time course after KCl stimulation,
showing that hippocalcin(T71N) and hippocalcin(A190T) increases calcium entry in response to depolarisation. Transfection control (n¼15), hippocalcin wild-type
(n¼13), hippocalcin(T71N) (n¼ 15) and hippocalcin(A190T) (n¼14). Data are expressed as mean6SEM. Statistical analysis was performed using hippocalcin as control
(Student t-test). (C) Maximum intracellular calcium increase and time course after KCl stimulation, showing that calcium entry in response to depolarisation is deter-
mined by N-type voltage-gated calcium channels. Hippocalcin wild-typeþ0.4 lM x-agatoxin IVA (n¼9), hippocalcin wild-typeþ 10lM x-conotoxin MVIIC (n¼10), hip-
pocalcin wild-typeþ1 lM x-conotoxin GVIA (n¼13), hippocalcin(A190T)þ0.4 lM x-agatoxin IVA (n¼14), hippocalcin(A190T)þ10 lM x-conotoxin MVIIC (n¼15),
hippocalcin(A190T)þ1 lM x-conotoxin GVIA (n¼22). Data are expressed as mean6SEM. Statistical analysis was performed using untreated hippocalcin or untreated
hippocalcin(A190T) as controls (Student t-test).
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restriction-ligation (BsaI/XhoI). DNA fragment encoding residues
1836-1983 from mouse N-type calcium channel asubunit
(NM_001042528) were obtained from GeneArt (Thermo Fisher
Scientific) using the following primers: sense, 5’-GGTCTCTAGGTA
AACCTGACGAGATGACAG-3’; antisense, 5’-ATATCTCGAGCTACC
CAGGCTGGGGCTCCCC-3’; and cloned into pE-SUMO by
restriction-ligation (BsaI/XhoI). The P/Q- fragment was chosen
according to previous work (62) and the N-type fragment was
designed as the region with greatest sequence homology to the P/
Q- fragment.
Cell culture and transfection
Cells were cultured in DMEM containing non-essential amino-
acids (Life Technologies), penicillin/streptomycin (100 U/ml,
100 lg/ml, respectively), at 37 C in an atmosphere of 5% CO2
in. Mouse N2A neuroblastoma culture medium was supple-
mented with 5% Heat inactivated FBS (Life Technologies)
whereas SH-SY5Y neuroblastoma cells were cultured in
DMEM/F-12 supplemented with 10% Heat inactivated FBS (Life
Technologies). SH-SY5Y neuroblastoma cells were differenti-
ated in DMEM/F-12 supplemented with 1% Heat inactivated
FBS (Life Technologies) and 10 lM retinoic acid for 3–5 days.
Cells were plated on 35-mm glass bottom culture dishes
(MatTek) and allowed 24 h to adhere before transfection with
FuGENE HD (Promega) following the manufacturer’s recom-
mendations. Cells were maintained for 12–24 h before being
used in experiments.
Expression and purification of hippocalcin and VGCCs
fragment proteins
Hippocalcin. Hippocalcin wild-type and mutant proteins were
overexpressed in E. coli BL21(DE3) STAR cells overnight at 20 C
after addition of 0.5 mM IPTG. Cells were resuspended in 50 mM
Naþ-HEPES, 200 mM NaCl, pH 7.5 containing EDTA-free
Complete protease inhibitor cocktail (Roche) and lysed by 1-h
incubation with 1 mg/ml of lysosyme and sonication on ice
(VibraCell, Jencons PLS). Lysates were incubated with benzonase
1 h on ice and clarified by ultra-centrifugation at 100,000g.
Clarified lysates were purified using 5 ml of GST resin (GST agar-
ose, ThermoFisher Scientific) equilibrated with 50 mM Naþ-
HEPES, 200 mM NaCl and GST-tag was cleaved using the
PreScission protease. The purified cleaved protein was further
purified on an AKTA Purifier using a Superdex 200 (26/60) gel fil-
tration column equilibrated with 50 mM Tris pH 7.5. Elution
fractions were concentrated on Centricon 10 kDa and aliquots
were stored at 80 C.
VGCCs. SUMO, SUMO-P/Q- and SUMO-N-type fragment pro-
teins were expressed as described above. Clarified lysates were
purified using 1 ml of Ni-NTA resin (QIAGEN) equilibrated with
50 mM Naþ-HEPES, 200 mM NaCl and eluted with 500 mM imida-
zole. Fractions were aliquoted and stored at 80 C.
Purity of the eluted fractions was determined by SDS-PAGE
(NuPAGE 4–12% Bis-Tris, NuPAGE MOPS SDS running buffer,
Life Technologies) and concentration was measured by spectro-
photometry at 280 nm (e0 (hippocalcin)¼ 20 065 M1 cm1), (e0 (P/
Q)¼ 27 515 M1 cm1), (e0 (N)¼ 28 028 M1 cm1), (e0 (SUMO)¼ 12 010
M1 cm1) (Nanodrop Lite, Thermo Scientific). Molar extinction
coefficient was calculated from the amino acid composition
using ExPASy/ProtParam program (10,63).
Biotinylation of hippocalcin proteins
Hippocalcin proteins or BSA (200 lg/ml¼ 10 lM) were incubated
with 100-fold molar excess of 6-(biotinamidocaproyamindo) N-
hydroxysuccimide ester (Sigma) for 2 h at room temperature.
Excess biotin reagent was removed by extensive dialysis against
20 mM Naþ-HEPES, 100 mM NaCl, pH 7.5. Biotinylated proteins
were aliquoted and stored at 80 C.
Equilibrium Ca2þ binding using tryptophan fluorescence
Hippocalcin proteins (1lM) were titrated with increasing CaCl2
concentrations in 50 mM Kþ-HEPES, 100 mM KCl, 2 mM MgCl2,
5 mM EGTA, pH 7.5. Intrinsic fluorescence was measured at
280 nm excitation and 340 nm emission wavelengths in a 1 ml
quartz cuvette using a JASCO FP-6300 spectrofluorimeter (Jasco)
at 20 C. All titrations were performed at least in triplicates and
expressed as mean6SEM. Data were corrected for dilution, nor-
malised and Ca2þ dissociation constant (Kd) and cooperativity
(n) were obtained by fitting to the Hill equation (Prism GraphPad
6). [Ca2þ] were calculated using the two-chelators Maxchelator
program (25) and verified by OGB-1 titration. Data were fitted to
a one-site specific binding equation using Prism GraphPad 6
software, giving a Kd for OGB-1 for Ca
2þ of 1326 11 nM, similar
to the value reported by Molecular Probes (Kd¼ 170 nM, in the
absence of Mg2þ).
Structure determination of hippocalcin proteins
Crystals for hippocalcin, hippocalcin(T71N) and hippocalcin
(A190T) proteins were grown at 20 C using the sitting drop
vapour diffusion method at a concentration of 50 mg/ml. Wild-
type protein crystallised in 0.1 M sodium citrate tribasic dihy-
drate pH 5.5, 18% v/v 2-propanol, 16% w/v PEG 4000.
Hippocalcin(A190T) crystallised in the same condition but with
20% w/v PEG 4000. Crystals were cryo-protected using paratone-
N and diffraction data were collected at Diamond synchrotron,
beamlines IO2, IO4-1 and IO4, data were processed by iMOSFLM
(64) and scaled by Aimless (65). Structure for wild-type protein
was solved by molecular replacement with MOLREP (66), using
NCS-1 (PDB 5AEQ) as a search model, structures of mutants
were refined starting from wild-type structure using REFMAC5
(67) in the CCP4 (68) programme suite with isotropic B-factors,
NCS restrains. TLS refinement was used during the last stages.
Rebuilding of the model between refinement cycles and adding
water molecules was performed in COOT (69). The quality of the
models was assessed on MolProbity (70) server. For wild-type
protein, residues from 6-188/7-189 for A190T mutant from 6-
189/7-190; for T71N mutant from 6-188/7-190, were clearly visi-
ble for both chains A and E, respectively, in spite of high Wilson
B-factor for all three data sets. Summary of diffraction data,
refinement statistics and the quality indicators for the struc-
tures are given in Supplementary Material, Table S1.
Oligomerisation of hippocalcin proteins
Size Exclusion Chromatography Multiangle Laser Light Scattering
(SEC-MALS). Hippocalcin proteins (100 ll) were separated on a
Superdex 200 10/300 GL gel filtration column (GE Healthcare Life
Sciences) equilibrated in 50 mM HEPES (pH 7.5) containing either
1 mM CaCl2 or 5 mM EGTA at 0.75 ml/min (AKTA Pure, GE
Healthcare). Protein elution was monitored by a Wyatt HELEOS-
II 18-angle laser photometer (DAWN8þ for light scattering
measurement, Wyatt Technology) and an Optilab rEX refractive
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index detector. Molar masses were obtained using the Astra
software (version 6.1.2.84) (Wyatt Technology).
Characterization of binding of biotinylated hippocalcin
proteins to VGCCs protein fragments
P/Q- (residues 1898-2035), N-type (residues 1836-1983) frag-
ments and SUMO (negative control) proteins were separated on
SDS-PAGE (NuPAGE 4–12% Bis-Tris, NuPAGE MOPS SDS running
buffer, Life Technologies) were blotted onto nitrocellulose mem-
branes for analysis. Biotinylated BSA was added to the samples
as loading control. Membranes were incubated in blocking solu-
tion (5% BSA in PBS, 0.2% Tween 20) at room temperature for 1 h
and then incubated overnight at 4 C with biotinylated probes at
5 lg/ml in 5% BSA in 50 mM Tris, 0.5 M NaCl, 0.5% Tween 20
(with or without the addition of 5 mM EGTA). Membranes were
washed 3 times in 50 mM Tris, 0.5 M NaCl, 0.5% Tween
2065 mM EGTA and incubated with Streptavidin-HRP conju-
gate (Amersham) peroxidase at 1:400 in blocking solution for
1 h. The membranes were washed 3 times as above, and bound
biotinylated proteins were detected using Pierce ECL western
blotting substrate (Thermo Scientific) on a ChemiDoc
XRSþ (Biorad).
Calcium imaging of hippocalcin wild-type and mutants
in differentiated SH-SY5Y cells
Differentiated SH-SY5Y cells were transfected with hippocalcin-
mCherry constructs and loaded with 1 lM Fluo-4-AM (Molecular
Probes) for 30 min in the absence or in the presence of 0.4 lM x-
agatoxin IVA (Abcam, P/Q-type calcium channel blocker), 10 lM
x-conotoxin MVIIC (Sigma, P/Q- and N-type calcium channel
blocker) or 1 lM x-conotoxin GVIA (Abcam, N-type calcium
channel blocker). Cells were examined at 37 C (OKO lab incuba-
tion chamber) in a 35-mm glass bottom dish (MatTek) with a 3i
Marianas spinning-disk confocal microscope equipped with a
Zeiss AxioObserver Z1, a 40x/1.3 oil immersion objective and a
3i Laserstack as excitation light source (488 nm, for Fluo-4;
561 nm, for hippocalcin-mCherry). Emitted light was collected
through single bandpass filters (Yokogawa CSU-X filter wheel)
onto a CMOS camera (Hamamatsu, ORCA Flash 4.0; 1152x1656
pixels).
Cells were stimulated with 50 mM KCl and images were col-
lected every 5 s for 1 min. The time course for intracellular cal-
cium influx was monitored over an elliptical region of interest
(ROI) in the cell body using ImageJ program. Data obtained from
9 to 22 cells was plotted and analysed on GraphPad Prism.
Data analysis and statistics
Results are expressed as mean6SEM unless indicated other-
wise. Biophysical experiments were performed at least in tripli-
cates and analysed using GraphPad Prism software. Cell
experiments were carried out on three independent prepara-
tions each. The total number of cells analysed in each condition
is given in the figure legends. Significance level was obtained
using Student t-test with the wild-type or untreated as control.
P values in the figures and tables are represented by stars
(*P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001, ns for non-
significant).
Supplementary Material
Supplementary Material is available at HMG online.
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Materials and Methods 
 
Determination of hippocalcin proteins stability. Trypsin limited proteolysis. Biotinylated hippocalcin proteins (20 g/ml) 
were incubated with trypsin (0.5 g/ml) for 0, 5, 10, 15, 20 and 30 min at 37 °C. The reaction was stopped using 5 mM PMSF. 
Degradation of hippocalcin was quantified by western blot (streptavidin-HRP conjugate) using ImageJ software. 
Heat denaturation. Heat stability of hippocalcin proteins was determined by following the unfolding of the -helices at 222 
nm using circular dichroism (JASCO J-1100 CD spectrometer, 200 l quartz cuvette, 0.1 cm path length). Samples (15 M) 
were measured in MilliQ water containing either 1 mM CaCl2 or 5 mM EGTA. Data was collected from 20 to 90 °C using 1 
°C increment and a ramp increase of 5°C/min. 
Guanidine denaturation. Chemical stability of hippocalcin proteins was determined by measuring the intrinsic tryptophan 
fluorescence after guanidine denaturation (JASCO FP-6300 fluorimeter, 1 mL quartz cuvette). Proteins (~ 10 M) in 50 mM 
K+-HEPES, 100 mM KCl, 2 mM MgCl2, pH 7.5, mixed with increasing concentration of guanidine ([Gnd-HCl] from 0 to 3 
M). Proteins were excited at 280 nm and fluorescence emission spectra were collected from 290 to 410 nm. 
Structure determination of hippocalcin proteins. Circular dichroism (CD) spectroscopy. CD spectra were recorded using a 
JASCO J-1100 spectrometer equipped with a JASCO MCB-100 mini circulation bath for temperature control. Far-UV CD 
spectra (180-260 nm) were recorded at 20 °C in a 0.1 cm path length quartz cell (5 accumulations, scan rate 50 nm.min-1). 
Proteins (15 M) were measured in MilliQ water containing either 1 mM CaCl2 or 5 mM EGTA. Secondary structure content 
was determined using CDSSTR prediction algorithm (DichroWeb online server) (1, 2). 
Oligomerisation of hippocalcin proteins. In vitro crosslinking. Hippocalcin purified proteins (10-20 M) were crosslinked 
using 20-50 fold molar excess of DSP or BS3 crosslinker (ThermoScientific) in the presence of 0.05-0.1-0.5-1 mM CaCl2 or 5 
mM EGTA. The mixture was incubated at room temperature for 30 min and the reaction was quenched by the addition of 50 
mM Tris for 10 min. 
In vivo crosslinking. N2A cells were grown on a 6-well plate in DMEM supplemented with 5% fetal bovine serum, 1x non-
essential amino-acids and 1% Penicillin-Streptomycin solution. At 90% confluence, cells were transfected using 
Lipofectamine™ 2000 (Invitrogen) following the manufacturer’s recommendations. Crosslinking was performed 24 hours 
post-transfection by washing the cells with PBS and incubated with 2 mM DSP for 30 min. After the reaction was stopped by 
50 mM Tris for 10 min, the cells were lysed in RIPA buffer for 30 min at 4°C. Clarified lysates were loaded on SDS-PAGE 
(NuPAGE 4-12% Bis-Tris, NuPAGE MOPS SDS running buffer, Life Technologies) with or without pre-incubation with a 
reducing agent to cleave the crosslinker (50 mM DTT for 30 min at 37°C), for Western blot analysis using anti-GFP monoclonal 
antibody (Roche) and densitometry quantification. 
Translocation experiment using photo-release/confocal imaging. Hippocalcin exhibits a Ca2+/myristoyl switch mechanism 
which allow the protein to remain cytosolic at resting calcium and to translocate to cellular membranes when intracellular 
3 
 
calcium concentration increases (10). SH-SY5Y cells transfected with hippocalcin-mCherry constructs were loaded with 1 M 
Fluo-4-AM (Molecular Probes) and 25 M NP-EGTA (Molecular Probes) and incubated in growth medium for 30 min at 37 
°C. Cells were examined in a 35-mm glass bottom dish (MatTek) with a 3i Marianas spinning-disk confocal microscope 
equipped with a Zeiss AxioObserver Z1, a 63x/1.4 oil immersion objective and a 3i Laserstack as excitation light source (405 
nm, for NP-EGTA photolysis; 488 nm, for Fluo-4; 561 nm, for hippocalcin-mCherry). Emitted light was collected through 
single bandpass filters (Yokogawa CSU-X filter wheel) onto a CMOS camera (Hamamatsu, ORCA Flash 4.0; 1152x1656 
pixels).  Experiments were carried out at 37 °C (OKO lab incubation chamber) and images were collected at 2 frames/s. To 
investigate the calcium-dependent translocation of hippocalcin, photolysis of NP-EGTA was performed by illumination with 
405-nm laser light at 10% power for 1 ms for rapid release of [Ca2+]. The time course for intracellular calcium release and 
hippocalcin translocation after photo-stimulation was monitored at the trans-Golgi network (TGN) over an elliptical region of 
interest (ROI). The mean background fluorescence was measured by ROI with the same dimensions placed at a point at which 
no cell was present. Fluo-4 and hippocalcin fluorescence changes were obtained from the background-corrected fluorescence 




Figure S1. Verification of [Ca2+] used for hippocalcin equilibrium titrations with OGB-1. A Kd value of 132 ± 11 nM was 









Figure S2. Effect of dystonia-causing mutations on trypsin, temperature and chemical susceptibility of hippocalcin. (a) Trypsin 
limited proteolysis of hippocalcin wild-type and mutants. Western blots of purified hippocalcin proteins were incubated with 
trypsin for 0, 5, 10, 15, 20 and 30 minutes at 37 °C. Bands were quantified by densitometry using ImageJ software. (b) Thermal 
unfolding of hippocalcin wild-type and mutants monitored by circular dichroism recorded at 222 nm from 20 to 90 °C. (c) 
Typical tryptophan emission spectra of hippocalcin and denaturation-induced fluorescence of hippocalcin wild-type and 
mutants as a function of [Gnd-HCl] (left panel). Quantification of the emission fluorescence at 340 nm as a function of Gnd-




Figure S3. Analysis of the secondary structures of hippocalcin wild-type and mutants using circular dichroism (CD) 
spectroscopy. (a) CD spectra were obtained in the presence of 5 mM EGTA (left panel) or 1 mM CaCl2 (right panel) and (b) 
protein secondary structure content was estimated using CDSSTR method (Johnson (1999); Whitmore and Wallace (2004)) 





Figure S4. Secondary and crystal structure of hippocalcin, hippocalcin(T71N) and hippocalcin(A190T). (a) Amino-acid and 
secondary structure alignment of full-length human hippocalcin and rat NCS-1. Positions of the dystonia-causing mutations are 
shown with a star. (b) Cartoon representation of the crystal packing of hippocalcin showing the long parallel protein fibrils 
morphology. (c) Alignment of hippocalcin crystal structure (magenta) with hippocalcin(T71N) (marine) and 
hippocalcin(A190T) (salmon) did not show any significant difference. Cartoon representation of the (d) hippocalcin(A190T) 
and (e) hippocalcin(T71N) structure. Details of the mutation site are shown as sticks. C-terminus is labelled with letter C, N-






Figure S5. Calcium-dependent oligomerisation of hippocalcin. (a) SDS-PAGE of hippocalcin purified proteins after in vitro 
crosslinking using BS3 crosslinker showing oligomer formation in the presence of calcium. Lane 1: molecular weight ladder, 
lane 2,6: hippocalcin wild-type, lane 3,7: hippocalcin(T71N), lane 4,8: hippocalcin(A190T), lane 2-4: in the presence of 5 mM 
EGTA, lane 6-8: in the presence of 1 mM CaCl2. (b) SDS-PAGE of hippocalcin purified proteins after in vitro crosslinking 
using DSP crosslinker showing oligomer formation in the presence of calcium. Lane 1: molecular weight ladder, lane 2,6,9: 
hippocalcin wild-type, lane 3,7,10: hippocalcin(T71N), lane 4,8,11: hippocalcin(A190T), lane 2-4: in the presence of 5 mM 
EGTA, lane 6-8: in the presence of 1 mM CaCl2, lane 9-11: in the presence of 1 mM CaCl2 and 50 mM DTT (left panel). Bands 
were quantified by densitometry using ImageJ (right panel). Light colors in the absence of calcium, dark colors in the presence 
of calcium. (c) Dimeric fraction of hippocalcin wild-type purified protein after in vitro crosslinking using DSP at [Ca2+] of 50 
M, 100 M, 500 M and 1 mM. Crosslink reactions were run on SDS-PAGE and analysed by densitometry using ImageJ. 
Data were normalised to the dimeric fraction obtained at 1 mM [Ca2+] and showed that 50 M [Ca2+] was sufficient to induce 
oligomer formation. (d) Western blot of in vivo crosslinking of N2A cells transfected with EGFP-hippocalcin using DSP 
showing that oligomerisation occurs at physiological conditions. Lane 1: molecular weight ladder, lane 3,7: hippocalcin wild-
type, lane 4,8: hippocalcin(T71N), lane 5,9: hippocalcin(A190T), lane 3-5: in the presence of 50 mM DTT, lane 7-9: in the 







Figure S6. Expression level of transfected SH-SY5Y cells with mCherry tagged hippocalcin (RFP antibody). Lane 1: molecular 
weight ladder, lane 2: hippocalcin wild-type, lane 3: hippocalcin(T71N), lane 4: hippocalcin(A190T). Calnexin, tubulin and 








Figure S7. Rapid translocation of hippocalcin wild-type and dystonia-causing mutants after flash photolysis of NP-EGTA. SH-
SY5Y cells transfected with hippocalcin-mCherry constructs were loaded with the calcium dye Fluo-4 and the calcium chelator 
NP-EGTA. After rapid calcium photorelease, live cells were imaged on a spinning-disk confocal microscope (n = 30). (a) 
Representative microscopy images before and after calcium photorelease revealed no significant alteration of translocation 
properties. Arrows indicate the location of the translocated hippocalcin after calcium photorelease. (b) Time course of 
intracellular calcium increase followed by Fluo-4 and hippocalcin translocation, showing that translocation occurs when 




Table S1.  Data collection and refinement statistics.  






HPCA HPCA A190T HPCA T71N 
Data collection 
Wavelength (Å) 
0.98 0.92 0.98 
Beamline  IO2 IO4 IO4-1 
Detector Pilatus Pilatus Pilatus 
Space group P61 P61 P61 
Unit-cell dimensions 
(a,b,c) (Å) 
50.91, 50.91, 283.02 50.66,   50.66,  283.46 51.16,   51.16,  284.06 
Resolution (Å) 43.56-2.42 (2.59-2.42) 43.87-2.54 (2.6-2.54) 47.3-3.00 (3.18-3.00) 
Rmerge % (last shell) 4.4  (63.0) 8.6(68) 12.8(57) 
I/σ (last shell) 11.7 (1.8) 8.7(1.9) 4.9(1.6) 
Completeness (%) 98.8 (99.9) 99.7(99.6) 99.0(99.0) 
Redundancy 3.3 (3.2) 4.6(4.4) 2.7(2.7) 
Wilson  B factor (Å2) 62 56 62 




23.3/27.1 21.9/24.9 21.9/28.3 
No. of atoms 
Protein 2996 2996 3021 
Ca ions 6 6 6 
Water 34 34 22 
B factor (Å2) 
Protein 57.8 55 78 
Ca2+ ions EF-2 75 73 83 
Ca2+ ions EF-3 83 77 85 
Ca2+ ions EF-4 105 71 78 
Waters 65 50 47 
R.M.S deviations 
Bond length (Å) 0.014 0.012 0.008 
Bond angles (°) 1.98 1.5 1.14 
PDB code  5g4p 5g58 5m6c 
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Table S2. Molar mass calculated from MALS data for HPCA and HPCA mutants in the presence or absence of calcium 
 
 
Molar mass (kDa) Molar mass (kDa) 
in the presence of 5 mM EGTA in the presence of 1 mM CaCl2 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 1 Peak 2 Peak 3 Peak 4 
HPCA 23.1 ± 0.2 45.5 ± 3.1 - - 25.1 ± 0.9 46.7 ± 1.1 68.2 ± 1.9 91.6 ± 2.9 
HPCA T71N 23.4 ± 0.3 34.5  ± 8.1 - - 24.1 ± 0.8 47.0  ± 0.2 65.7  ± 2.3 - 
HPCA N75K 23.0 ± 0.2 - - - 22.5 ± 0.9 42.8  ± 1.9 65.9  ± 1.9 - 
HPCA A190T 22.9 ± 0.2 44.8  ± 0.5 - - 23.8 ± 0.2 44.5  ± 1.1 63.9  ± 0.6 - 
 
 
 
 
